Safety and Efficacy of Lutikizumab (ABT-981), An Anti–Interleukin-1 Alpha/Beta Dual Variable Domain (DVD) Immunoglobulin, in Subjects with Knee Osteoarthritis: Results from the Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2 Trial

Safety and Efficacy of Lutikizumab (ABT-981), An Anti–Interleukin-1 Alpha/Beta Dual Variable Domain (DVD) Immunoglobulin, in Subjects with Knee Osteoarthritis: Results from the Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2 Trial

Read the publication >

Contact Us

Phone Icon

T: +44 7413 022053

Email Icon

E: contact@ia-grp.com

Address Icon

8thFloor, 1 Butterwick, Hammersmith, London, W6 8DL United Kingdom

or

Pennovation, 3401 Grays Ferry Ave, Philadelphia, PA 19146, USA